Status:
ACTIVE_NOT_RECRUITING
Poznan Prospective Study of Type 1 Diabetic Patients
Lead Sponsor:
Poznan University of Medical Sciences
Conditions:
Microangiopathy
Macroangiopathy
Eligibility:
All Genders
18-35 years
Brief Summary
The purpose of this study is to evaluate the development and progression of chronic complications (retinopathy, neuropathy, diabetic chronic renal disease, cardiovascular events) in patients with type...
Eligibility Criteria
Inclusion
- Newly diagnosed type 1 diabetes mellitus with features of complete insulin deficiency (serum C-peptide level \<0.05 ng/ml, acetonuria, blood gases disturbances such as: pH \<7.30, BE\< -6 mmol/l, HCO3 \<18 mmol/l)
- Age \< 35 years old
- Educational course in intensive insulin therapy started at the onset of the disease after treatment of ketoacidosis
- Written consent
Exclusion
- Uncertain type of diabetes mellitus
- Kidney failure (serum creatinine level \> 1.1 mg/dl)
- Liver dysfunction (AspAt \> 31 U/l, AlAt \> 34 U/l)
- Acute inflammatory process
- Other concomitant diseases (i.e. neoplasm)
Key Trial Info
Start Date :
January 1 1994
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01411033
Start Date
January 1 1994
End Date
December 1 2028
Last Update
December 5 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.